MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202647067570 A) filed by Regeneron Pharmaceuticals, Inc. on May 29, 2026, for Methods For Reducing Lipase Activity Using Stress.
Inventors include Tang, Xiaolin; and Breydo, Leonid.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: Pharmaceutical formulations comprising an antibody that specifically binds to human interleukin-4 receptor alpha (hIL-4Ra) are provided. The formulations may contain, in addition to an anti-IL-4Ra antibody, one or more buffers, at least one amino acid, at least one sugar, and a surfactant. Methods for producing pharmaceutical formulations with reduced lipase activity are als...